Dr. Gaiti is an early career investigator at the Princess Margaret Cancer Centre, Assistant Professor in the Dept. of Medical Biophysics at the University of Toronto, and Early Career Research Affiliate at OICR. He earned his PhD in evolutionary biology and genomics from the University of Queensland (Australia) in 2017, where he focused on understanding the evolutionary origin of two major players in human gene regulation: long non-coding RNAs and chromatin marks. As a postdoctoral fellow in the laboratory of Dr. Dan Landau at Weill Cornell Medicine and New York Genome Center, he studied the epigenetic determinants of cancer evolution using novel single-cell multi-omics experimental and computational approaches in blood disorders and brain tumors. These works have been published in highly esteemed journals including Nature, Nature Genetics, and Nature Communications. His work has been further recognized by prestigious federal agencies (NIH, CIHR, NSERC) and awards, including the Emerging Leaders in Computational Oncology Award and the Ontario Institute Cancer Research Investigator Award. Dr. Gaiti research program is focused on developing and applying single-cell multi-omics approaches to answer the fundamental question of how malignant cellular states are jointly determined by genetic and epigenetic alterations, aiming to develop novel therapeutic strategies to directly anticipate and address cancer evolutionary capacity.
Website: https://www.gaitilab.com/